IV Synercid
March 2000
Aventis is now marketing IV Synercid.
Synercid contains the two new streptogramin antibiotics...quinupristin and dalfopristin.
It will be used as a "last resort" in treating vancomycin-resistant Enterococcus faecium (VREF).
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote